[Problem analysis. Evaluation of therapeutic means and objectives].
There is an inadequacy between the increasingly effective antiarrhythmia drugs at our disposal for the treatment of ventricular arrhythmias, their increasingly accurate and standardised evaluation by different invasive and non-invasive methods, and the pertinence of their clinical usage, especially in terms of patient safety. The reason why this situation has occurred are analysed in order to review a number of beliefs which have been too easily adopted without sufficient discussion.